Brief: Myriad Genetics Q1 Operating Income USD -27.9 Million
07/05/2024 21:05
May 07 (Reuters) - Myriad Genetics Q1 adjusted operating income USD -600 thousand. * Q1 adjusted operating expenses USD 139.1 million * Q1 gross margin 68.1% * Q1 operating expenses USD 165.5 million
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple